Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Nora D. Volkow, Carlos Blanco
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 203-229
Open Access | Times Cited: 120
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

Journal of Addiction Medicine (2024) Vol. 18, Iss. 1S, pp. 1-56
Closed Access | Times Cited: 16
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Luis Antonio Díaz, Daniel König, Sabine Weber, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
Baclofen for alcohol use disorder
Roberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
Karel H. van der Pol, Mohamad Aljofan, Olivier Blin, et al.
Applied Health Economics and Health Policy (2023) Vol. 21, Iss. 6, pp. 831-840
Open Access | Times Cited: 23
Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study
Broc A. Pagni, Petros Petridis, Samantha K. Podrebarac, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential
Ravinder Naik Dharavath, Celeste Pina‐Leblanc, Victor M. Tang, et al.
Frontiers in Neural Circuits (2023) Vol. 17
Open Access | Times Cited: 18
Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease
Kamil Litwinowicz, Andrzej Gamian
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2461-2461
Open Access | Times Cited: 17
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments
David Prince, Emily Nash, Ken Liu
Drugs (2023) Vol. 83, Iss. 16, pp. 1459-1474
Open Access | Times Cited: 15
Alterations and correlations of gut microbiota, fecal, and serum metabolome characteristics in a rat model of alcohol use disorder
Xiaolong Wang, Lin Li, Cong Bian, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 14
A Bayesian meta-analysis of topiramate’s effectiveness for individuals with alcohol use disorder
Dimy Fluyau, Vasanth Kattalai Kailasam, Christopher G. Pierre
Journal of Psychopharmacology (2023) Vol. 37, Iss. 2, pp. 155-163
Closed Access | Times Cited: 13
Medications for the Treatment of Alcohol Dependence—Current State of Knowledge and Future Perspectives from a Public Health Perspective
Iga Stokłosa, Gniewko Więckiewicz, Maciej Stokłosa, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1870-1870
Open Access | Times Cited: 13
Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender
Dylan Kirsch, Malia A. Belnap, Elizabeth M. Burnette, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 1, pp. 81-93
Closed Access | Times Cited: 5
Gut microbiome in alcohol use disorder: Implications for health outcomes and therapeutic strategies-a literature review
Ilias Koutromanos, Evangelia Legaki, Maria Gazouli, et al.
World Journal of Methodology (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
Giuseppe Guido Maria Scarlata, Carmen Colaci, Marialaura Scarcella, et al.
(2024)
Open Access | Times Cited: 5
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 5
Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment.
Giovanni Addolorato, Hannu Alho, Paula B. M. de Andrade, et al.
European Journal of Internal Medicine (2024) Vol. 127, pp. 43-49
Open Access | Times Cited: 4
A Comparative Study of Phenolic, Flavonoid and Antioxidant Compounds for Spath and Male Flower of Phoenix dactylifera L.: Extraction Method and Solvent Effects
Khadijeh Asadi, Roja Safaeian, Sedigheh Babaei, et al.
Deleted Journal (2025) Vol. 67, Iss. 1
Closed Access
Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches.
Emilio Merlo Pich, Ioannis Tarnanas, Patrizia Brigidi, et al.
Neurobiology of Stress (2025) Vol. 35, pp. 100713-100713
Open Access
ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions
Mariely Hernández, Frances R. Levin, Aimee Campbell
CNS Drugs (2025)
Closed Access
Eye Movement Desensitization and Reprocessing Intervention in Preventing Craving in Alcohol Use Disorder: A Pilot Randomized Controlled Trial
Yağmur Callak Sarğın, Zeki Yüncü, Umut Kırlı
Journal of EMDR Practice and Research (2025) Vol. 19
Closed Access
Cannabidiol attenuates precuneus activation during appetitive cue exposure in individuals with alcohol use disorder
Tristan Hurzeler, Warren Logge, Joshua Watt, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Open Access
Changes in the Properties of Ethanol-Sensitive Molecular Targets During Maturation and Aging
Luis G. Aguayo, Lorena Armijo‐Weingart, Loreto San Martín, et al.
Advances in experimental medicine and biology (2025), pp. 299-316
Closed Access
Monitoring and treatment of alcohol use disorder: An integrated multidisciplinary model
Ashwani K. Singal
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Addictions and Substance Misuse

(2025), pp. 477-560
Closed Access
Page 1 - Next Page

Scroll to top